1. Home
  2. ZIM vs PBLS Comparison

ZIM vs PBLS Comparison

Compare ZIM & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ZIM Integrated Shipping Services Ltd.

ZIM

ZIM Integrated Shipping Services Ltd.

HOLD

Current Price

$25.01

Market Cap

3.0B

ML Signal

HOLD

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$30.76

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZIM
PBLS
Founded
1945
N/A
Country
Israel
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.6B
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
ZIM
PBLS
Price
$25.01
$30.76
Analyst Decision
Hold
Analyst Count
5
0
Target Price
$19.26
N/A
AVG Volume (30 Days)
1.1M
502.7K
Earning Date
05-20-2026
N/A
Dividend Yield
7.65%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.49
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.33
$25.56
52 Week High
$29.97
$33.65

Technical Indicators

Market Signals
Indicator
ZIM
PBLS
Relative Strength Index (RSI) 51.79 56.52
Support Level $23.11 $26.83
Resistance Level $26.16 $33.65
Average True Range (ATR) 0.58 2.62
MACD 0.12 0.14
Stochastic Oscillator 70.26 63.76

Price Performance

Historical Comparison
ZIM
PBLS

About ZIM ZIM Integrated Shipping Services Ltd.

ZIM Integrated Shipping Services Ltd is an asset-light container liner shipping company. It offers tailored services, including land transportation and logistical services, specialized shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. Its services include Cargo Services, Digital Services, Schedules, and Shipping Trades and Lines. Geographically, it derives a majority of its revenue from the Pacific trade region.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: